Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation (Q37279900)

From Wikidata

Jump to navigation Jump to search

scientific article published on 19 June 2009

Language	Label	Description	Also known as
English	Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation	scientific article published on 19 June 2009

Statements

scholarly article

1 reference

Europe PubMed Central

19 August 2017

Cost-effectiveness of micafungin as an alternative to fluconazole empiric treatment of suspected ICU-acquired candidemia among patients with sepsis: a model simulation (English)

1 reference

Europe PubMed Central

19 August 2017

0 references

cost-effectiveness analysis

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

3

object named as

Andrew F Shorr

1 reference

Europe PubMed Central

19 August 2017

Marya D Zilberberg

1

object named as

Marya D Zilberberg

1 reference

Europe PubMed Central

19 August 2017

author name string

Smita Kothari

2

1 reference

Europe PubMed Central

19 August 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

19 June 2009

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

13

1 reference

Europe PubMed Central

19 August 2017

3

1 reference

Europe PubMed Central

19 August 2017

R94

1 reference

Europe PubMed Central

19 August 2017

https://scigraph.springernature.com/pub.10.1186/cc7924

0 references

Impact of invasive fungal infection on outcomes of severe sepsis: a multicenter matched cohort study in critically ill surgical patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

6 September 2017

When is critical care medicine cost-effective? A systematic review of the cost-effectiveness literature

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

6 September 2017

Empirical anti-Candida therapy among selected patients in the intensive care unit: a cost-effectiveness analysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

6 September 2017

Delaying the empiric treatment of candida bloodstream infection until positive blood culture results are obtained: a potential risk factor for hospital mortality

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

6 September 2017

Appropriate empirical antibacterial therapy for nosocomial infections: getting it right the first time

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

6 September 2017

The epidemiology of sepsis in the United States from 1979 through 2000

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

6 September 2017

Secular trends of candidemia over 12 years in adult patients at a tertiary care hospital

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

6 September 2017

Epidemiology, treatment and outcome of candidemia: a five-year review at three Canadian hospitals

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

6 September 2017

The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

6 September 2017

Distribution of variable vs fixed costs of hospital care

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

6 September 2017

Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

6 September 2017

Clinical importance of delays in the initiation of appropriate antibiotic treatment for ventilator-associated pneumonia

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

14 September 2017

Empirical fluconazole versus placebo for intensive care unit patients: a randomized trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

14 September 2017

Candidemia: the impact of antifungal prophylaxis in a surgical intensive care unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

14 September 2017

Recommendations of the Panel on Cost-effectiveness in Health and Medicine

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

28 September 2017

Magnitude and duration of the effect of sepsis on survival. Department of Veterans Affairs Systemic Sepsis Cooperative Studies Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

26 June 2018

Treatment-related risk factors for hospital mortality in Candida bloodstream infections

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

3 September 2018

Inappropriate therapy for methicillin-resistant Staphylococcus aureus: resource utilization and cost implications

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

3 September 2018

Risk factors for albicans and non-albicans candidemia in the intensive care unit

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

3 September 2018

Sepsis in European intensive care units: results of the SOAP study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

3 September 2018

Cost effectiveness of drotrecogin alfa (activated) for the treatment of severe sepsis in the United Kingdom.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

3 September 2018

Linezolid for treatment of ventilator-associated pneumonia: a cost-effective alternative to vancomycin

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

3 September 2018

A prospective observational study of candidemia: epidemiology, therapy, and influences on mortality in hospitalized adult and pediatric patients.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

3 September 2018

Secular trend of hospital-acquired candidemia among intensive care unit patients in the United States during 1989-1999.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

3 September 2018

Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

3 September 2018

Nosocomial infections in medical intensive care units in the United States. National Nosocomial Infections Surveillance System

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2717466

3 September 2018

Risk factors for candidal bloodstream infections in surgical intensive care unit patients: the NEMIS prospective multicenter study. The National Epidemiology of Mycosis Survey

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost savings attributable to reductions in intensive care unit length of stay for mechanically ventilated patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cost-effectiveness of recombinant human activated protein C and the influence of severity of illness in the treatment of patients with severe sepsis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guidelines for treatment of candidiasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

EPISEPSIS: a reappraisal of the epidemiology and outcome of severe sepsis in French intensive care units

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Medical care services in the Consumer Price Index

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Modification of empiric antibiotic treatment in patients with pneumonia acquired in the intensive care unit. ICU-Acquired Pneumonia Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Time to Initiation of Fluconazole Therapy Impacts Mortality in Patients with Candidemia: A Multi‐Institutional Study

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Do clinical features allow for accurate prediction of fungal pathogenesis in bloodstream infections? Potential implications of the increasing prevalence of non-albicans candidemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Epidemiology, risk factors, and outcomes of Candida albicans versus non-albicans candidemia in nonneutropenic patients

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

National health spending in 2006: a year of change for prescription drugs

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Secular trends in candidemia-related hospitalization in the United States, 2000-2005

1 reference

https://pubmed.ncbi.nlm.nih.gov/19545361

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

1 reference

Europe PubMed Central

19 August 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

19 August 2017

1 reference

Europe PubMed Central

19 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q37279900&oldid=1795568202"